Royal London Asset Management
DXCM icon

Royal London Asset Management’s DexCom DXCM Stock Holding History

Royal London Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Sell
186,879
-387
-0.2% -$25.8K 0.02% 417
2026
Q1 		$11.8M Buy
187,266
+305
+0.2% +$21.2K 0.02% 428
2025
Q4 		$12.4M Sell
186,961
-821
-0.4% -$53.1K 0.03% 411
2025
Q3 		$12.6M Buy
187,782
+4,770
+3% +$377K 0.03% 410
2025
Q2 		$16M Sell
183,012
-2,233
-1% -$175K 0.04% 367
2025
Q1 		$12.7M Buy
185,245
+14,296
+8% +$1.17M 0.03% 396
2024
Q4 		$13.3M Buy
170,949
+7,711
+5% +$571K 0.03% 378
2024
Q3 		$10.9M Buy
163,238
+5,733
+4% +$471K 0.03% 408
2024
Q2 		$17.9M Buy
157,505
+4,853
+3% +$614K 0.05% 296
2024
Q1 		$21.2M Buy
152,652
+182
+0.1% +$22.9K 0.05% 272
2023
Q4 		$18.9M Buy
152,470
+4,044
+3% +$413K 0.05% 272
2023
Q3 		$13.8M Buy
148,426
+6,954
+5% +$784K 0.04% 299
2023
Q2 		$18.2M Buy
141,472
+6,356
+5% +$769K 0.06% 259
2023
Q1 		$15.7M Buy
135,116
+437
+0.3% +$48.9K 0.06% 237
2022
Q4 		$15.3M Buy
134,679
+4,047
+3% +$444K 0.07% 234
2022
Q3 		$10.5M Sell
130,632
-8,441
-6% -$715K 0.05% 288
2022
Q2 		$10.4M Buy
139,073
+3,533
+3% +$322K 0.05% 291
2022
Q1 		$17.3M Buy
135,540
+2,864
+2% +$313K 0.07% 228
2021
Q4 		$17.8M Sell
132,676
-1,936
-1% -$278K 0.07% 225
2021
Q3 		$18.4M Buy
134,612
+1,560
+1% +$197K 0.07% 209
2021
Q2 		$14.2M Sell
133,052
-5,464
-4% -$525K 0.06% 267
2021
Q1 		$12.5M Buy
138,516
+3,892
+3% +$365K 0.06% 273
2020
Q4 		$12.4M Sell
134,624
-4,620
-3% -$413K 0.07% 246
2020
Q3 		$14M Buy
139,244
+3,256
+2% +$340K 0.08% 198
2020
Q2 		$13.5M Sell
135,988
-4,864
-3% -$435K 0.09% 201
2020
Q1 		$9.77M Hold
140,852
– – 0.08% 222
2019
Q4 		$7.61M Hold
140,852
– – 0.05% 321
2019
Q3 		$5.25M Buy
140,852
+4,196
+3% +$163K 0.04% 393
2019
Q2 		$5.16M Buy
136,656
+4,460
+3% +$140K 0.05% 344
2019
Q1 		$4.99M Buy
+132,196
New +$4.65M 0.04% 433

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royal London Asset Management's DXCM Position: Q2 2026 in Review

Royal London Asset Management reduced its DexCom (DXCM) stake by 0.21% in Q2 2026, selling an estimated $25.8K and leaving 186,879 shares worth $12.6M. The position accounts for 0.02% of the portfolio, ranked #417.

Royal London Asset Management first reported a position in DXCM in Q1 2019 and has held it in 30 quarters since. The position peaked at $21.2M in Q1 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Royal London Asset Management held 186,879 shares of DexCom worth $12.6M as of Q2 2026.
  • Royal London Asset Management sold 387 DexCom shares in Q2 2026, an estimated $25.8K.
  • DexCom made up 0.02% of Royal London Asset Management's portfolio in Q2 2026, its #417 holding.
  • Royal London Asset Management first reported a position in DexCom in Q1 2019 and has held it in 30 quarters since.
  • Royal London Asset Management's DexCom position peaked at $21.2M in Q1 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Royal London Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.